Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: Is there a link?

Expert Review of Medical Devices

Volumn 9, Issue 4, 2012, Pages 377-388

  Pedersen, Susanne S ^a,b   Brouwers, Corline ^a   Versteeg, Henneke ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

arrhythmias; distress; implantable cardioverter defibrillator; mechanisms; mortality; psychological vulnerability

Indexed keywords

ARRHYTHMIAS; BIOMEDICAL RISKS; CARDIAC DEATH; CLINICAL PRACTICES; CUMULATIVE EVIDENCE; DISEASE SEVERITY; DISTRESS; MORTALITY; POTENTIAL RISKS; PSYCHOLOGICAL FACTORS; PSYCHOLOGICAL VULNERABILITY; VENTRICULAR TACHYARRHYTHMIAS;

MECHANISMS;

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS;

ANXIETY; DEFIBRILLATOR; DEPRESSION; DISEASE SEVERITY; EMOTIONAL DISORDER; HEART DEPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INFLAMMATION; MENTAL HEALTH; MENTAL STRESS; MOOD DISORDER; MORTALITY; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SUDDEN DEATH; THROMBOCYTE ACTIVATION;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; RISK FACTORS; STRESS, PSYCHOLOGICAL; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84865488494     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.12.31     Document Type: Review

References (87)

1. Bardy GH, Lee KL, Mark DB et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352(3), 225-237 (2005). (Pubitemid 40110811)
2. Epstein AE. Benefits of the implantable cardioverter-defibrillator. J. Am. Coll. Cardiol. 52(14), 1122-1127 (2008).
3. Epstein AE, DiMarco JP, Ellenbogen KA et al.; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 51(21), e1-e62 (2008). (Pubitemid 351689050)
4. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann. Intern. Med. 138(6), 445-452 (2003).
5. Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. Pacing Clin. Electrophysiol. 23(6), 934-938 (2000). (Pubitemid 30413598)
6. Carlson MD, Wilkoff BL, Maisel WH et al.; American College of Cardiology Foundation; American Heart Association; International Coalition of Pacing and Electrophysiology Organizations. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm 3(10), 1250-1273 (2006).
7. Crespo EM, Kim J, Selzman KA. The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: A review of the evidence and implications. Am. J. Med. Sci. 329(5), 238-246 (2005). (Pubitemid 40695451)
8. Wilkoff BL, Williamson BD, Stern RS et al.; PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J. Am. Coll. Cardiol. 52(7), 541-550 (2008).
9. Maisel WH. Safety issues involving medical devices: Implications of recent implantable cardioverter-defibrillator malfunctions. JAMA 294(8), 955-958 (2005). (Pubitemid 41215465)
10. Jackson LR 2nd, Daubert JP, Thomas KL. Expanding the benefits of implantable cardioverter-defibrillator therapy: 'is less more'? Prog. Cardiovasc. Dis. 54(4), 372-378 (2012).
11. Bardy GH, Smith WM, Hood MA et al. An entirely subcutaneous implantable cardioverter-defibrillator. N. Engl. J. Med. 363(1), 36-44 (2010).
12. Buxton AE. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm 6(6), 836-847 (2009). Seminal paper highlighting the complexity of risk stratification for sudden cardiac death, and emphasizing that we are still at large with respect to identifying the subset of patients at risk for sudden cardiac death.
13. Amit G, Rosenbaum DS, Super DM, Costantini O. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: Implications for identifying patients at risk for sudden cardiac death. Heart Rhythm 7(6), 763-768 (2010).
14. Exner DV, Kavanagh KM, Slawnych MP et al.; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J. Am. Coll. Cardiol. 50(24), 2275-2284 (2007). (Pubitemid 350192102)
15. Steinberg JS, Arshad A, Kowalski M et al. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack. J. Am. Coll. Cardiol. 44(6), 1261-1264 (2004). (Pubitemid 39208882)
16. Shedd OL, Sears SF Jr, Harvill JL et al. The World Trade Center attack: Increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. J. Am. Coll. Cardiol. 44(6), 1265-1267 (2004). (Pubitemid 39208883)
17. Magyar-Russell G, Thombs BD, Cai JX et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. J. Psychosom. Res. 71(4), 223-231 (2011). First systematic review on the prevalence of anxiety and depression in implantable cardioverter defibrillator (ICD) patients, indicating that 20-25% of patients suffer from psychological distress.
18. Versteeg H, Theuns DA, Erdman RA, Jordaens L, Pedersen SS. Posttraumatic stress in implantable cardioverter defibrillator patients: The role of preimplantation distress and shocks. Int. J. Cardiol. 146(3), 438-439 (2011).
19. Habibovic M, van den Broek KC, Alings M, Van der Voort PH, Denollet J. Posttraumatic stress 18 months following cardioverter defibrillator implantation: Shocks, anxiety, and personality. Health Psychol. 31(2), 186-193 (2012).
20. Pedersen SS, den Broek KC, Theuns DA et al. Risk of chronic anxiety in implantable defibrillator patients: A multi-center study. Int. J. Cardiol. 147(3), 420-423 (2011).
21. Sears SF, Kirian K. Shock and patientcentered outcomes research: Is an ICD shock still a critical event? Pacing Clin. Electrophysiol. 33(12), 1437-1441 (2010).
22. Pedersen SS, Versteeg H, Nielsen JC, Mortensen PT, Johansen JB. Patientreported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. Europace 13(9), 1292-1298 (2011).
23. Suzuki T, Shiga T, Kuwahara K et al. Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: A 2-year longitudinal study. Pacing Clin. Electrophysiol. 33(12), 1455-1461 (2010).
24. Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator. Am. J. Cardiol. 108(1), 69-74 (2011).
25. Pedersen SS, Sears SF, Burg MM, Van Den Broek KC. Does ICD indication affect quality of life and levels of distress? Pacing Clin. Electrophysiol. 32(2), 153-156 (2009).
26. Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Pre implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation. Int. J. Cardiol. doi:10.1016/j. ijcard.2011.10.092 (2011) (Epub ahead of print).
27. Pedersen SS, Schiffer AA. The distressed (Type D) personality. A risk marker for poor health outcomes in ICD patients. Herzschrittmacherther. Elektrophysiol. 22(3), 181-188 (2011).
28. Chair SY, Lee CK, Choi KC, Sears SF. Quality of life outcomes in Chinese patients with implantable cardioverter defibrillators. Pacing Clin. Electrophysiol. 34(7), 858-867 (2011).
29. Dunbar SB, Kimble LP, Jenkins LS et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress. Anxiety 9(4), 163-168 (1999). First study to support a link between psychological distress and risk of ventricular tachyarrhythmia. (Pubitemid 29316079)
30. Whang W, Albert CM, Sears SF Jr et al.; TOVA Study Investigators. Depression as a predictor for appropriate shocks among patients with implantable cardioverterdefibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) study. J. Am. Coll. Cardiol. 45(7), 1090-1095 (2005). (Pubitemid 40432444)
31. Piotrowicz K, Noyes K, Lyness JM et al. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur. Heart J. 28(5), 601-607 (2007). (Pubitemid 47355502)
32. Dougherty CM, Hunziker J. Predictors of implantable cardioverter defibrillator shocks during the first year. J. Cardiovasc. Nurs. 24(1), 21-28; quiz 29 (2009).
33. Shalaby A, Brumberg G, El-Saed A, Saba S. Mood disorders and outcome in patients receiving cardiac resynchronization therapy. Pacing Clin. Electrophysiol. 35(3), 294-301 (2012).
34. Fries R, König J, Schäfers HJ, Böhm M. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin. Cardiol. 25(10), 474-478 (2002).
35. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 106(14), 1800-1805 (2002).
36. Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shockterminated arrhythmias. Psychosom. Med. 66(6), 898-902 (2004). (Pubitemid 39552874)
37. van den Broek KC, Nyklícek I, van der Voort PH, Alings M, Meijer A, Denollet J. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J. Am. Coll. Cardiol. 54(6), 531-537 (2009).
38. Denollet J. DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom. Med. 67(1), 89-97 (2005).
39. Kao CW, Friedmann E, Thomas SA. Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Qual. Life Res. 19(3), 307-315 (2010).
40. Steinberg JS, Joshi S, Schron EB, Powell J, Hallstrom A, McBurnie M; AVID Investigators. Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm 5(3), 361-365 (2008).
41. Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: Results from the prospective living with an implanted cardioverter-defibrillator study. Arch. Gen. Psychiatry 65(11), 1324-1330 (2008). First study to demonstrate a link between post-traumatic stress disorder and mortality in ICD patients.
42. Pedersen SS, van den Broek KC, Erdman RA, Jordaens L, Theuns DA. Preimplantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 12(10), 1446-1452 (2010). Seminal study showing that patients with a Type D personality or patients with a high preimplantation level of ICD concerns (i.e., patient concerns about the ICD giving a shock irrespective of whether patients have actually received a shock) increase the risk of mortality in ICD patients. Patients with clustering of both psychological risk markers compared with patients with only one or none of these markers had a further attenuated risk.
43. Tzeis S, Kolb C, Baumert J et al. Effect of depression on mortality in implantable cardioverter defibrillator recipients-findings from the prospective LICAD study. Pacing Clin. Electrophysiol. 34(8), 991-997 (2011).
44. van den Broek KC, Tekle FB, Habibovic M, Alings M, van der Voort PH, Denollet J. Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. Int. J. Cardiol. doi:10.1016/j. ijcard.2011.08.071 (2011) (Epub ahead of print).
45. York KM, Hassan M, Sheps DS. Psychobiology of depression/distress in congestive heart failure. Heart Fail. Rev. 14(1), 35-50 (2009).
46. Veith RC, Lewis N, Linares OA et al. Sympathetic nervous system activity in major depression. Basal and desipramineinduced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51(5), 411-422 (1994). (Pubitemid 24176819)
47. Battipaglia I, Barone L, Mariani L et al. Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 12(12), 1725-1731 (2010).
48. Francis JL, Weinstein AA, Krantz DS et al. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosom. Med. 71(8), 821-827 (2009).
49. Carney RM, Howells WB, Blumenthal JA et al. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom. Med. 69(1), 4-9 (2007). (Pubitemid 46148359)
50. Sánchez Muñoz JJ, García-Alberola A, Martínez-Sánchez J et al. Premature ventricular complexes as a trigger for ventricular fibrillation. Rev. Esp. Cardiol. 63(7), 798-801 (2010).
51. Barthel P, Schneider R, Bauer A et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 108(10), 1221-1226 (2003). (Pubitemid 37099991)
52. Whang W, Julien HM, Higginbotham L et al. Women, but not men, have prolonged QT interval if depressed after an acute coronary syndrome. Europace 14(2), 267-271 (2012).
53. Carney RM, Freedland KE, Stein PK et al. Effects of depression on QT interval variability after myocardial infarction. Psychosom. Med. 65(2), 177-180 (2003). (Pubitemid 36359328)
54. Rajamani S, Eckhardt LL, Valdivia CR et al. Drug-induced long QT syndrome: HERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br. J. Pharmacol. 149(5), 481-489 (2006). (Pubitemid 44658508)
55. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: A meta-analysis. J. Am. Coll. Cardiol. 46(1), 75-82 (2005). (Pubitemid 40905133)
56. Lampert R, Shusterman V, Burg M et al. Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators. J. Am. Coll. Cardiol. 53(9), 774-778 (2009). Seminal study indicating that angerinduced T-wave alternans predict future ventricular arrhythmias. This study supports the concept that there are plausible mechanisms linking psychological mood states to clinical outcome in ICD patients.
57. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom. Med. 65(2), 181-193 (2003). (Pubitemid 36359329)
58. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J. Clin. Invest. 90(2), 389-398 (1992).
59. Givertz MM, Colucci WS. New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress. Lancet 352(Suppl. 1), SI34-SI38 (1998). (Pubitemid 28398690)
60. von Känel R, Hepp U, Kraemer B et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 41(9), 744-752 (2007). (Pubitemid 46659723)
61. Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts C, Vrints CJ. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int. J. Cardiol. 113(1), 34-38 (2006). (Pubitemid 44648357)
62. Blangy H, Sadoul N, Dousset B et al. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 9(9), 724-729 (2007). (Pubitemid 47371644)
63. Konstantino Y, Kusniec J, Reshef T et al. Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients. Clin. Cardiol. 30(8), 408-413 (2007). (Pubitemid 47312892)
64. Geiser F, Meier C, Wegener I et al. Association between anxiety and factors of coagulation and fibrinolysis. Psychother. Psychosom. 77(6), 377-383 (2008).
65. Serrano CV Jr, Setani KT, Sakamoto E, Andrei AM, Fraguas R. Association between depression and development of coronary artery disease: Pathophysiologic and diagnostic implications. Vasc. Health Risk Manag. 7, 159-164 (2011).
66. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104(16), 1894-1898 (2001). (Pubitemid 32983230)
67. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J. Card. Fail. 10(3), 258-271 (2004). (Pubitemid 38869468)
68. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch. Intern. Med. 165(21), 2508-2513 (2005). (Pubitemid 41720013)
69. Whooley MA, de Jonge P, Vittinghoff E et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300(20), 2379-2388 (2008).
70. Bunevicius A, Stankus A, Brozaitiene J, Girdler SS, Bunevicius R. Relationship of fatigue and exercise capacity with emotional and physical state in patients with coronary artery disease admitted for rehabilitation program. Am. Heart J. 162(2), 310-316 (2011).
71. van Ittersum M, de Greef M, van Gelder I, Coster J, Brügemann J, van der Schans C. Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator. Int. J. Rehabil. Res. 26(2), 117-122 (2003). (Pubitemid 36819935)
72. Zen AL, Whooley MA, Zhao S, Cohen BE. Post-traumatic stress disorder is associated with poor health behaviors: Findings from the Heart and Soul Study. Health Psychol. 31(2), 194-201 (2012).
73. Licinio J, Wong ML. The interface of obesity and depression: Risk factors for the metabolic syndrome. Rev. Bras. Psiquiatr. 25(4), 196-197 (2003). (Pubitemid 37376762)
74. Thorndike AN, Regan S, McKool K et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch. Intern. Med. 168(2), 186-191 (2008). (Pubitemid 351185886)
75. Tabacco or Health? Physiological and Social Damages Causes by Tobacco Smoking (2nd Edition). Haustein KO, Groneberg D. Springer-Verlag, Berlin Heidelberg, Germany (2010).
76. McGrady A, McGinnis R, Badenhop D, Bentle M, Rajput M. Effects of depression and anxiety on adherence to cardiac rehabilitation. J. Cardiopulm. Rehabil. Prev. 29(6), 358-364 (2009).
77. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160(14), 2101-2107 (2000). (Pubitemid 30482715)
78. Pelle AJ, Schiffer AA, Smith OR, Widdershoven JW, Denollet J. Inadequate consultation behavior modulates the relationship between type D personality and impaired health status in chronic heart failure. Int. J. Cardiol. 142(1), 65-71 (2010).
79. Singh JP, Ellenbogen KA, Desai NR, McAlister FA. ICDs, guidelines, and national registries: Opportunities to enhance quality of patient care. Pacing Clin. Electrophysiol. 35(3), 253-258 (2012).
80. Mark DB, Nelson CL, Anstrom KJ et al.; SCD-HeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114(2), 135-142 (2006). (Pubitemid 44420745)
81. Zwanziger J, Hall WJ, Dick AW et al. The cost effectiveness of implantable cardioverter-defibrillators: Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J. Am. Coll. Cardiol. 47(11), 2310-2318 (2006). (Pubitemid 43795065)
82. Braunschweig F, Boriani G, Bauer A et al. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. Europace 12(12), 1673-1690 (2010).
83. Pedersen SS, Kupper N, van Domburg RT. Heart and mind: Are we closer to disentangling the relationship between emotions and poor prognosis in heart disease? Eur. Heart J. 32(19), 2341-2343 (2011).
84. The Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press, DC, USA (2001).
85. Salmoirago-Blotcher E, Ockene IS. Methodological limitations of psychosocial interventions in patients with an implantable cardioverter- defibrillator (ICD) A systematic review. BMC Cardiovasc. Disord. 9, 56 (2009).
86. Donahue RG, Lampert R, Dornelas E, Clemow L, Burg MM; RISTA Investigators. Rationale and design of a randomized clinical trial comparing stress reduction treatment to usual cardiac care: The Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) trial. Psychosom. Med. 72(2), 172-177 (2010).
87. Pedersen SS, Spek V, Theuns DA et al. Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverterdefibrillator patients to reduce anxiety and device concerns and enhance quality of life. Trials 10, 120 (2009).